{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T03:36:19Z","timestamp":1783654579372,"version":"3.55.0"},"reference-count":26,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Res Protoc"],"abstract":"\n Background<\/jats:title>\n Human papillomavirus (HPV) is the most common sexually transmitted infection worldwide and imposes a significant public health burden. In 2019, HPV was responsible for approximately 620,000 cancer cases in women, 70,000 in men, and more than 300,000 deaths globally. Despite the proven efficacy of the vaccine, vaccination rates remain alarmingly low in certain regions of France. In R\u00e9union Island, only 16% of girls and 9% of boys under 16 years old were fully vaccinated in 2024. This underscores the need for increased awareness, education, and outreach programs. Peer learning is well-established in health education, whereas serious game\u2013style card games are newer and require further research. Both methods have been shown to improve knowledge on specific topics.<\/jats:p>\n <\/jats:sec>\n \n Objective<\/jats:title>\n The main objective of this study is to assess the impact of 2 awareness-raising strategies on increasing HPV vaccination rates among middle school students by actively involving them in the process.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n This protocol describes the design of a randomized, open-label, controlled trial aimed at evaluating the effectiveness of 2 awareness-raising interventions\u2014peer learning and a card-based serious game\u2014in improving HPV vaccination rates among middle school students in R\u00e9union Island. The study will span an entire school year, beginning in August. Approximately 3600 students from 24 middle schools in R\u00e9union Island will be included, with schools randomized into 3 groups of 8 each: (1) a control group receiving the existing national vaccination campaign initiated by the French public health institute; (2) ambassador classes, whose students will receive education about the HPV vaccine and later educate other students in the same school; and (3) serious game card group, where students can play and learn about HPV during a science class. The primary outcome will be the proportion of teenagers who initiate the vaccination process, compared across the 3 groups using appropriate statistical methods. Anonymized data will be collected at the end of the school year using social security records. Teenagers\u2019 knowledge of HPV will be assessed both before and 3 months after each intervention, and satisfaction will also be evaluated after the intervention in each group.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n As of May 2025, a preliminary result enrolling 124 students showed an increase in vaccination coverage after students played a serious game. We expect higher vaccination rates in the intervention groups compared with the control group, although it is difficult to predict which strategy will be more effective. The estimated target vaccination coverage for groups b and c is 45%.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n This study aims to improve HPV vaccination rates among teenagers in R\u00e9union Island by evaluating the impact of 2 awareness-raising strategies using innovative and engaging tools. If successful, this approach could be adapted and implemented in other regions of France or internationally.<\/jats:p>\n <\/jats:sec>\n \n International Registered Report Identifier (IRRID)<\/jats:title>\n PRR1-10.2196\/73366<\/jats:p>\n <\/jats:sec>","DOI":"10.2196\/73366","type":"journal-article","created":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T07:25:06Z","timestamp":1756193106000},"page":"e73366","source":"Crossref","is-referenced-by-count":1,"title":["Boosting Human Papillomavirus Vaccination Rates: Protocol for a Randomized Controlled Trial of Awareness Interventions in R\u00e9union Island"],"prefix":"10.2196","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-9949-8919","authenticated-orcid":false,"given":"Julie","family":"Duclaud","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3962-8869","authenticated-orcid":false,"given":"Antoine","family":"Bertolotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0109-489X","authenticated-orcid":false,"given":"Emmanuel","family":"Chirpaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5341-9758","authenticated-orcid":false,"given":"Jessica","family":"Sambourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1313-940X","authenticated-orcid":false,"given":"Kevin","family":"Diallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7561-239X","authenticated-orcid":false,"given":"Vincent","family":"Balaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3283-1450","authenticated-orcid":false,"given":"Phuong Lien","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,10,27]]},"reference":[{"key":"ref1","unstructured":"Institut PasterCancer du col de l'ut\u00e9rus et Papillomavirus (HPV)Cancer du col de l'ut\u00e9rus et Papillomavirus (HPV)202309012025-07-15https:\/\/www.pasteur.fr\/fr\/centre-medical\/fiches-maladies\/cancer-du-col-uterus-papillomavirus-hpv"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(23)00305-4"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-011-2155-8"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/s2214-109x(19)30488-7"},{"key":"ref5","unstructured":"Sant\u00e9 Publique FranceEtude Pr\u00e9vIST 2022-2023202501232025-07-15https:\/\/www.santepubliquefrance.fr\/etudes-et-enquetes\/etude-previst-2022-2023#:~:text=En%202022%2C%20Sant%C3%A9%20publique%20France,les%20facteurs%20de%20risque%20associ%C3%A9s"},{"issue":"2023\/N\u00b0 Supp 1 Vol. 11","key":"ref6","first-page":"13","volume":"11","author":"Derancourt, C","year":"2023","journal-title":"Dermato Mag"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/978-2-287-72066-6_48"},{"key":"ref8","unstructured":"Agence R\u00e9gionale de Sant\u00e9 la R\u00e9unionEnqu\u00eate de couverture vaccinale \u00e0 La R\u00e9union en 2022202411072025-07-15https:\/\/www.lareunion.ars.sante.fr\/enquete-de-couverture-vaccinale-la-reunion-en-2022"},{"key":"ref9","unstructured":"Bilan de la campagne de vaccination contre les infections \u00e0 papillomavirus humain (HPV) men\u00e9e au coll\u00e8ge dans les classes de 5e au cours de l?ann\u00e9e scolaire 2023-2024 en FranceSant\u00e9 publique Francehttps:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/documents\/enquetes-etudes\/bilan-de-la-campagne-de-vaccination-contre-les-infections-a-papillomavirus-humain-hpv-menee-au-college-dans-les-classes-de-5e-au-cours-de-l-annee"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2021.102277"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2023.03.033"},{"key":"ref12","unstructured":"DaviesCSkinnerSRSchool-based vaccination is key to reducing HPV-related diseasesHPVWorld202382025-10-14https:\/\/www.HPVWorld.com"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.29024\/aogh.24"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/jocn.15661"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/930901"},{"key":"ref16","unstructured":"JulianADamienDOlivierRApprendre avec les serious games ?Apprendre avec les serious games ?202502142025-07-15https:\/\/hal.science\/hal-02533902v1"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4212\/cjhp.v72i5.2933"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.2196\/27443"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0245389"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jogoh.2025.102941"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.01.046"},{"key":"ref22","unstructured":"The World Medical Association (WMA)2025-09-22http:\/\/www.wma.net"},{"key":"ref23","unstructured":"Sant\u00e9 Publique FranceVaccination en France. Bilan de la couverture vaccinale en 2023202404262025-07-15https:\/\/www.santepubliquefrance.fr\/determinants-de-sante\/vaccination\/documents\/bulletin-national\/vaccination-en-france.-bilan-de-la-couverture-vaccinale-en-2023#:~:text=La%20couverture%20vaccinale%20au%20moins,estim%C3%A9e%20%C3%A0%2035%2C1%20%25"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.316.7142.1455"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines10111923"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3109\/01421599309029007"}],"container-title":["JMIR Research Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.researchprotocols.org\/2025\/1\/e73366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:03:57Z","timestamp":1782842637000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchprotocols.org\/2025\/1\/e73366"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,27]]},"references-count":26,"URL":"https:\/\/doi.org\/10.2196\/73366","relation":{"has-preprint":[{"id-type":"doi","id":"10.2196\/preprints.73366","asserted-by":"object"}]},"ISSN":["1929-0748"],"issn-type":[{"value":"1929-0748","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,27]]}}}